AP control of as the most efficacious tool for the prevention of cardiovascular complications in patients with type 2 diabetes mellitus
Эксперты прогнозируют значительный рост заболеваемости СД2 в ближайшие 10?15 лет. Неблагоприятный прогноз у этих больных определяется высоким риском развития кардио- и цереброваскулярных осложнений. Применение фиксированной комбинации периндоприла с индапамидом (нолипрел) у больных СД2 независимо от...
Saved in:
| Main Author: | Yury Alexandrovich Karpov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2009-06-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5390 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tasks and objectives of the ADVANCE study. Design of the study. Rationale for the use of diabeton MB
by: Olga Mikhailovna Smirnova
Published: (2009-06-01) -
Commentary on prevention of cardiovascular complications in diabetes mellitus as novel inidicationfor Diabeton MR
by: Olga Konstantinovna Vikulova
Published: (2012-06-01) -
Intestinal microecology and its impact on microvascular complications in elderly type 2 diabetes mellitus patients
by: Chen Jinglian, et al.
Published: (2025-03-01) -
PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01) -
Platelet Indices: Predicting Retinopathy in Patients with Type 2 Diabetes Mellitus
by: Arijit Paul, et al.
Published: (2024-11-01)